SCHEMBL22302013

SCHEMBL22302013

CCC(C)N1CC2(CN(C(C)C)C2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19083175 0.83 CYP2D6 (0.32)
SCHEMBL22318088 0.82
SCHEMBL10111451 0.82 SMN1; SMN2 (0.37)
SCHEMBL22317788 0.81
SCHEMBL26137689 0.79 ALDH1A1 (0.30)
SCHEMBL18559500 0.77 TSHR (0.32)
SCHEMBL22966960 0.77 ALDH1A1 (0.32)
SCHEMBL15259312 0.77
SCHEMBL21339483 0.76 TSHR (0.33)
SCHEMBL19823684 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160193-A2 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2020-08-06 WO disclosed